WARDWIZARD HEALTHCARE LIMITED Stock Price Today (NSE: WARDHEALTH)
Fundamental Score
WARDWIZARD HEALTHCARE LIMITED Share Price — Live NSE/BSE Price, Fundamentals & Analysis
WARDWIZARD HEALTHCARE LIMITED share price today is ₹45.34, up +0.00% on NSE/BSE as of 30 March 2026. WARDWIZARD HEALTHCARE LIMITED (WARDHEALTH) is a Small-cap company in the Trading & Distributors sector with a market capitalisation of ₹1.01 (Cr). The 52-week high for WARDHEALTH share price is ₹45.34 and the 52-week low is ₹18.00.
WARDWIZARD HEALTHCARE LIMITED Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
WARDWIZARD HEALTHCARE LIMITED Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
WARDWIZARD HEALTHCARE Share Price: A Conservative Value Investor's Perspective
In the often-opaque world of Trading & Distributors, robust financial health is paramount. Investors must discern genuine growth from transient market hype. This analysis examines the "WARDWIZARD HEALTHCARE share price" through the lens of a conservative value investor, emphasizing capital preservation above all else. Currently trading at ₹45.34, a quick glance reveals some red flags. The absence of a Price-to-Earnings (PE) ratio immediately indicates a lack of current profitability, a concern for investors prioritizing consistent earnings.
A critical metric is Return on Capital Employed (ROCE), which paints a concerning picture. WARDWIZARD HEALTHCARE LIMITED's ROCE of -58.66% signifies a substantial inability to generate profits from its capital investments. This negative ROCE severely erodes any potential economic moat the company might hope to establish. A strong moat, the ability to protect profits and market share from competitors, is crucial for long-term value creation. A -58.66% ROCE suggests significant competitive disadvantages or internal inefficiencies.
Comparing WARDWIZARD HEALTHCARE LIMITED to its peers, such as
Ganon Products Ltd, requires a deeper dive into management quality and execution. While objective metrics are crucial, assessing the competency and integrity of leadership is equally important. If Ganon Products Ltd. demonstrates superior capital allocation and profitability ratios despite similar market conditions, it suggests a potential difference in management effectiveness that warrants further investigation.From a capital safety perspective, the negative ROCE and lack of current profitability are significant warning signs. While turnaround stories are possible, they require a high degree of investor risk tolerance and a very strong conviction in future improvements. For a conservative value investor, focusing on businesses with established profitability, positive ROCE, and a demonstrated ability to generate free cash flow is generally a more prudent approach. This analysis is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, designed to identify potential investment risks and opportunities.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
WARDWIZARD HEALTHCARE LIMITED Fundamental Analysis & Valuation Benchmarking
Educational evaluation of WARDHEALTH across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Robust Profit Growth (62.32%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (69.52% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Balanced Promoter Holding (74.08%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Suboptimal ROCE (-58.66%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-202.80%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Interest Coverage (-4.48x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-2.07 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
WARDWIZARD HEALTHCARE LIMITED Financial Statements
Comprehensive financial data for WARDWIZARD HEALTHCARE LIMITED including income statement, balance sheet and cash flow
About WARDHEALTH (WARDWIZARD HEALTHCARE LIMITED)
WARDWIZARD HEALTHCARE LIMITED is a dynamic entity operating within the trading and distribution sector, with a specific focus on healthcare solutions. Established in 1985 and headq...uartered in Vadodara, India, WARDHEALTH distinguishes itself by connecting diverse aspects of healthcare, from the sourcing and distribution of pharmaceutical products and medical devices to facilitating access to alternative therapies. The company acts as a crucial link between manufacturers, healthcare providers, and ultimately, patients, ensuring the efficient and reliable flow of vital medical supplies and information. Beyond conventional medical avenues, WARDHEALTH demonstrates a commitment to holistic well-being by integrating traditional Ayurvedic practices into its operational framework, signifying a dedication to encompassing both modern and time-honored approaches to health management. WARDHEALTH's operational scope extends beyond simple distribution; it cultivates a network built on trusted relationships and a comprehensive understanding of the healthcare landscape. This allows the company to adapt to evolving market demands and regulatory changes, ensuring its continued relevance and reliability in the dynamic healthcare industry. Furthermore, the company's trading activities are conducted with a strong emphasis on quality assurance and ethical sourcing, guaranteeing that the products and services it facilitates meet the highest standards. This commitment to integrity builds trust among partners and end-users alike, reinforcing WARDHEALTH's reputation as a dependable and responsible player in the market. Operating under the WARDWIZARD banner since its name change in August 2023, the company leverages its extensive experience to bridge gaps in the healthcare ecosystem. WARDHEALTH focuses on building efficient supply chains, optimizing logistical processes, and fostering collaborative partnerships. This dedication is aimed to broaden access to essential healthcare resources. By focusing on improving distribution networks and product availability, WARDHEALTH seeks to positively impact health outcomes and contribute to the overall well-being of communities it serves. The company's focus on both traditional and modern healthcare solutions distinguishes it within the trading and distribution sector, reflecting a multifaceted approach to health and wellness.
Company Details
Key Leadership
WARDHEALTH Share Price: Frequently Asked Questions
What is the current share price of WARDWIZARD HEALTHCARE LIMITED (WARDHEALTH)?
As of 30 Mar 2026, 11:00 am IST, WARDWIZARD HEALTHCARE LIMITED share price is ₹45.34. The WARDHEALTH stock has a market capitalisation of ₹1.01 (Cr) on NSE/BSE.
Is WARDHEALTH share price Overvalued or Undervalued?
WARDHEALTH share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 35.45x. Based on this relative valuation, the WARDWIZARD HEALTHCARE LIMITED stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of WARDHEALTH share price?
The 52-week high of WARDHEALTH share price is ₹45.34 and the 52-week low is ₹18.00. These values are updated daily from NSE/BSE price data.
What factors affect the WARDWIZARD HEALTHCARE LIMITED share price?
Key factors influencing WARDHEALTH share price include quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is WARDWIZARD HEALTHCARE LIMITED a good stock for long-term investment?
WARDWIZARD HEALTHCARE LIMITED shows a 5-year Profit Growth of N/A% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of N/A before investing in WARDHEALTH shares.
How does WARDWIZARD HEALTHCARE LIMITED compare with its industry peers?
WARDWIZARD HEALTHCARE LIMITED competes with major peers in the Trading & Distributors. Investors should compare WARDHEALTH share price P/E of 0.00x and ROE of N/A% against the industry averages to determine competitive standing.
What is the P/E ratio of WARDHEALTH and what does it mean?
WARDHEALTH share price has a P/E ratio of N/Ax compared to the industry average of 35.45x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is WARDHEALTH performing according to Bull Run's analysis?
WARDHEALTH has a Bull Run fundamental score of 28/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does WARDHEALTH belong to?
WARDHEALTH operates in the Trading & Distributors industry. This classification helps understand the competitive landscape and sector-specific trends affecting WARDWIZARD HEALTHCARE LIMITED share price.
What is Return on Equity (ROE) and why is it important for WARDHEALTH?
WARDHEALTH has an ROE of N/A%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently WARDWIZARD HEALTHCARE LIMITED generates profits from shareholders capital.
How is WARDHEALTH debt-to-equity ratio and what does it indicate?
WARDHEALTH has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk.
What is WARDHEALTH dividend yield and is it a good dividend stock?
WARDHEALTH offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in WARDWIZARD HEALTHCARE LIMITED shares.
How has WARDHEALTH share price grown over the past 5 years?
WARDHEALTH has achieved 5-year growth rates of: Sales Growth 69.52%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in WARDHEALTH and why does it matter?
Promoters hold 74.08% of WARDHEALTH shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in WARDWIZARD HEALTHCARE LIMITED.
What is WARDHEALTH market capitalisation category?
WARDHEALTH has a market capitalisation of ₹1 crores, placing it in the Small-cap category.
How volatile is WARDHEALTH stock?
WARDHEALTH has a beta of N/A. A beta > 1 suggests the WARDWIZARD HEALTHCARE LIMITED stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is WARDHEALTH operating profit margin trend?
WARDHEALTH has a 5-year average Operating Profit Margin (OPM) of -202.80%, indicating the company's operational efficiency.
How is WARDHEALTH quarterly performance?
Recent quarterly performance shows WARDWIZARD HEALTHCARE LIMITED YoY Sales Growth of -100.00% and YoY Profit Growth of 62.32%.
What is the institutional holding pattern in WARDHEALTH?
WARDHEALTH has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the WARDWIZARD HEALTHCARE LIMITED stock.